Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy

Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy

Acute infection is known to induce strong anti-tumor immune responses, but clinical translation has been hindered by the lack of an effective strategy to safely and consistently provoke a therapeutic response. These limitations are overcome with a novel treatment approach involving repeated subcutan...

Full description

Bibliographic Details
Main Authors: Mark Bazett, Amanda M. Costa, Momir Bosiljcic, Rebecca M. Anderson, Matthew P. Alexander, Stephanie W. Y. Wong, Salim Dhanji, Jenny MH Chen, Jim Pankovich, Stephen Lam, Simon Sutcliffe, Hal Gunn, Shirin Kalyan, David W. Mullins
Format: Article
Language:English
Published: Taylor & Francis Group 2018-03-01
Series:OncoImmunology
Subjects:
immunotherapy
innate immunity
klebsiella
lung cancer
nk cells
nkg2d
nsclc
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1398875

Internet

http://dx.doi.org/10.1080/2162402X.2017.1398875

Similar Items